-
Product Insights
NewPTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTA Peripheral DCB Catheters Pipeline Market Report Overview A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis or restenosis of the peripheral arteries. PTA Peripheral DCB catheters provide fast, short-term, homogenous, local drug delivery to the vessel wall while preserving the anatomy of the vessel, promoting enhanced vessel healing, and reducing the need for prolonged dual antiplatelet therapy. They can be used to treat native and in-stent restenosis (ISR), bifurcations, small vessels,...
-
Product Insights
NewPTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. The PTCA Drug Coated Balloon (DCB) Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Product Insights
NewLeft Atrial Appendage Closure Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Left Atrial Appendage Closure Devices Pipeline Market Report Overview Left atrial appendage closure device prevents blood flow into the left atrial appendage, preventing blood clotting or pooling. It consists of left atrial appendage implanted occlusion devices and left atrial appendage ligation devices. One unit refers to one left atrial appendage closure device. The left atrial appendage closure devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development....
-
Product Insights
NewCardiac Ablation Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Ablation Devices Pipeline Market Report Overview Cardiac ablation devices use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The cardiac ablation devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Innovation Ranking
NewInnovation Ranking – LifeTech Scientific Corporation
LifeTech Scientific Corp (LifeTech Scientific) develops, manufactures and markets advanced minimally invasive interventional medical_x000D_ devices for cardiovascular and peripheral vascular diseases and disorders. The company offering products includes occluders, stent-graft systems, delivery systems, vena cava fitter, vascular plug, sizing ballon, dilator and snare systems, abdominal aortic aneurysm stent graft and steerable introducer, among others. LifeTech Scientific business includes structural heart diseases, peripheral vascular diseases and cardiac pacing and electrophysiology business. The company offers products under the brands LAmbre, CeraFlex, Cera,...
-
Sector Analysis
NewInferior Vena Cava Filters (IVCF) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Inferior Vena Cava Filters (IVCF) Market Report Overview The inferior vena cava filters (IVCF) market was valued at $128 million in 2023 and will decline at a CAGR of more than 1% during 2023-2033. IVCF is a metallic device used to prevent blood clots from traveling to the lungs. The filter is inserted inside a large vein called the inferior vena cava (IVC). IVC filter traps blood clots before they reach the lungs. IVCF Market Outlook 2023-2033 ($ Million) For...
-
Sector Analysis
Aortic Stent Grafts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Aortic Stent Grafts Market Report Overview The aortic stent grafts market size was $3.31 billion in 2023. The market is expected to grow at a CAGR of more than 7% during 2023-2033. Aortic Stent grafts are used to reinforce a weakened aorta to prevent ruptures. These devices can be of allografts or synthetic materials. Aortic Stent Grafts Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights into the Aortic Stent Grafts Market Forecast Download a Free Report...
-
Product Insights
Malaria – Drugs In Development, 2023
Global Markets Direct’s, ‘Malaria - Drugs In Development, 2023’, provides an overview of the Malaria pipeline landscape. The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Recessive X Chromosome Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Recessive X Chromosome Disorders - Drugs In Development, 2023’, provides an overview of the Recessive X Chromosome Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Recessive X Chromosome Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Duchenne Muscular Dystrophy – Drugs In Development, 2023
Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Drugs In Development, 2023’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Duchenne Muscular Dystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...